An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells.
Medical Terms & Definitions Glossary
An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Medical Terminology DB · Copyright © 2024 · Privacy · Terms of Use · Disclaimer · XML Sitemap
Leave a Comment